home.social

#hematology — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #hematology, aggregated by home.social.

fetched live
  1. When red blood cells break down, they release heme, an essential, oxygen-transporting component of hemoglobin. Once outside the red blood cell, free heme acts as a harmful agent that can trigger severe inflammatory reactions and damage tissues and blood vessels.
    #Hematology #Immunology #Pathology #CellBiology #sflorg
    sflorg.com/2026/09/bio09012601

  2. When red blood cells break down, they release heme, an essential, oxygen-transporting component of hemoglobin. Once outside the red blood cell, free heme acts as a harmful agent that can trigger severe inflammatory reactions and damage tissues and blood vessels.
    #Hematology #Immunology #Pathology #CellBiology #sflorg
    sflorg.com/2026/09/bio09012601

  3. When red blood cells break down, they release heme, an essential, oxygen-transporting component of hemoglobin. Once outside the red blood cell, free heme acts as a harmful agent that can trigger severe inflammatory reactions and damage tissues and blood vessels.
    #Hematology #Immunology #Pathology #CellBiology #sflorg
    sflorg.com/2026/09/bio09012601

  4. When red blood cells break down, they release heme, an essential, oxygen-transporting component of hemoglobin. Once outside the red blood cell, free heme acts as a harmful agent that can trigger severe inflammatory reactions and damage tissues and blood vessels.
    #Hematology #Immunology #Pathology #CellBiology #sflorg
    sflorg.com/2026/09/bio09012601

  5. When red blood cells break down, they release heme, an essential, oxygen-transporting component of hemoglobin. Once outside the red blood cell, free heme acts as a harmful agent that can trigger severe inflammatory reactions and damage tissues and blood vessels.
    #Hematology #Immunology #Pathology #CellBiology #sflorg
    sflorg.com/2026/09/bio09012601

  6. Fibrinogen, a key blood-clotting protein, forms multiple flat layers when it contacts air, rather than a single tilting layer as previously thought.
    #Fibrinogen #Biochemistry #Biophysics #Hematology #sflorg
    sflorg.com/2026/08/bchm0820260

  7. Fibrinogen, a key blood-clotting protein, forms multiple flat layers when it contacts air, rather than a single tilting layer as previously thought.
    #Fibrinogen #Biochemistry #Biophysics #Hematology #sflorg
    sflorg.com/2026/08/bchm0820260

  8. Fibrinogen, a key blood-clotting protein, forms multiple flat layers when it contacts air, rather than a single tilting layer as previously thought.
    #Fibrinogen #Biochemistry #Biophysics #Hematology #sflorg
    sflorg.com/2026/08/bchm0820260

  9. Fibrinogen, a key blood-clotting protein, forms multiple flat layers when it contacts air, rather than a single tilting layer as previously thought.
    #Fibrinogen #Biochemistry #Biophysics #Hematology #sflorg
    sflorg.com/2026/08/bchm0820260

  10. Fibrinogen, a key blood-clotting protein, forms multiple flat layers when it contacts air, rather than a single tilting layer as previously thought.
    #Fibrinogen #Biochemistry #Biophysics #Hematology #sflorg
    sflorg.com/2026/08/bchm0820260

  11. Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
    #MolecularGenetics #Hematology #Oncology #CellBiology #Leukemia #sflorg
    sflorg.com/2026/08/gen08102601

  12. Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
    #MolecularGenetics #Hematology #Oncology #CellBiology #Leukemia #sflorg
    sflorg.com/2026/08/gen08102601

  13. Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
    #MolecularGenetics #Hematology #Oncology #CellBiology #Leukemia #sflorg
    sflorg.com/2026/08/gen08102601

  14. Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
    #MolecularGenetics #Hematology #Oncology #CellBiology #Leukemia #sflorg
    sflorg.com/2026/08/gen08102601

  15. Inherited genetic abnormalities in the SLF2 and SMC5 genes have been identified as a previously unrecognized cause of inherited bone marrow failure syndrome (IBMFS) and a driver of predisposition to myelodysplastic syndromes (MDS).
    #MolecularGenetics #Hematology #Oncology #CellBiology #Leukemia #sflorg
    sflorg.com/2026/08/gen08102601

  16. Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

    Adult B-ALL exhibits significant …
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Acutelymphocyticleukaemia #Biomedicine #CancerResearch #Clinicaltrials #general #Health #Hematology #Oncology
    newsbeep.com/us/789712/

  17. Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

    Adult B-ALL exhibits significant …
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #Acutelymphocyticleukaemia #Biomedicine #CancerResearch #Clinicaltrials #general #Health #Hematology #Oncology
    newsbeep.com/us/789712/

  18. europesays.com/ie/608599/ Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study #AcuteLymphocyticLeukaemia #Biomedicine #CancerResearch #ClinicalTrials #Éire #general #Health #hematology #IE #Ireland #Medication #oncology

  19. europesays.com/uk/1116492/ Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study #AcuteLymphocyticLeukaemia #Biomedicine #CancerResearch #ClinicalTrials #general #Health #hematology #Medication #oncology #UK #UnitedKingdom

  20. Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study

    Adult B-ALL exhibits significant heterogeneity and poor prog…
    #NewsBeep #News #Medication #Acutelymphocyticleukaemia #Biomedicine #CancerResearch #ClinicalTrials #general #Health #Hematology #Oncology #UK #UnitedKingdom
    newsbeep.com/uk/715729/

  21. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  22. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  23. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  24. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  25. Hemodialysis patients with blood type A exhibit significantly lower risks of both all-cause and cardiovascular mortality compared to those with other blood types. This finding directly contrasts with the general population, where blood type O is typically associated with the lowest risk of cardiovascular disease.
    #Nephrology #Cardiology #Hematology #Epidemiology #sflorg
    sflorg.com/2026/07/med07212601

  26. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  27. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  28. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  29. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  30. Researchers have successfully generated red blood cell-like cells capable of producing hemoglobin by utilizing canine induced pluripotent stem cells (iPSCs).
    #VeterinaryMedicine #StemCellBiology #Genetics #Hematology #sflorg
    sflorg.com/2026/07/vet07202601

  31. US FDA Approves Sanofi’s Wearable Injector Form of Blood Cancer Drug

    The U.S. Food and Drug Administration has approved a wearable injector formulation of Sanofi’s blood cancer drug Sarclisa,…
    #France #FR #Europe #EU #Sanofi #bloodcancer #cancercareinnovation #FDAapproval #hematology #infusiontimereduction #multiplemyeloma #on-bodyinjector #Oncology #Sarclisa #SarclisaEscena #subcutaneousdelivery #wearableinjector
    europesays.com/france/50500/

  32. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  33. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  34. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  35. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  36. Acute myeloid leukemia (AML) is driven not only by gene mutations but also by its epigenome—specifically, the chromatin state that dictates which genes are active. By mapping these accessible genome regions, researchers have established a new framework that classifies AML into sixteen distinct epigenetic subgroups.
    #Oncology #Epigenomics #MolecularBiology #Hematology #sflorg
    sflorg.com/2026/07/ongy0709260

  37. New Atellica HEMA 580 Analyzer from Siemens Healthineers helps labs deliver fast, consistent results to improve clinical decision-making

    Siemens Healthineers now offers U.S. laboratories a comprehensive hematology solution that brings together automation, middleware, and remote digital…
    #Germany #DE #Europe #EU #Europa #Siemens #automation #Blood #Hematology #Laboratory #Morphology #siemens
    europesays.com/germany/50474/

  38. 2026 EHA | Over 40 Orelabrutinib Studies Presented,

    BEIJING, June 15, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing…
    #Europe #EU #BeijingInnoCarePharmaTechCo. #biotech #EHA #Hematology #HongKongStockExchange:9969 #Ltd. #Orelabrutinib
    europesays.com/europe/69510/

  39. europesays.com/ch/69491/ Novartis advances RLT innovation and reinforces leadership in prostate cancer, breast cancer and hematology with new data at ASCO and EHA #Advances #and #ASCO #at #breast #cancer #data #EHA #hematology #in #Innovation #Leadership #new #Novartis #prostate) #reinforces #RLT #With

  40. Higher ferritin threshold could detect childhood iron deficiency much earlier

    Many cases of iron deficiency in school-aged children could be diagnosed earlier, according to a new study published…
    #NewsBeep #News #Health #Anemia #AU #Australia #Blood #Cell #Children #Fatigue #hematology #Hemoglobin #irondeficiency #Menstruation #Nutrition #Obesity #physicalactivity #protein #RedBloodCells
    newsbeep.com/au/683335/